A.O.U. Policlinico-Vittorio Emanuele, University of Catania, Catania, Italy.
EuroIntervention. 2019 Nov 20;15(10):857-866. doi: 10.4244/EIJ-D-19-00788.
Transcatheter aortic valve implantation (TAVI) has, in less than 20 years, become the dominant interventional treatment for aortic stenosis in developed countries. Its development has been characterised by the growth of procedural expertise and device improvement. Every aspect of this therapy has been investigated, increasing clinical evidence and leading to continued optimisation. The purpose of this review article is to provide an overview of the rapidly changing field of TAVI therapy, briefly describing key past achievements and discussing residual challenges.
经导管主动脉瓣植入术（TAVI）在不到 20 年的时间里已成为发达国家治疗主动脉瓣狭窄的主导介入治疗方法。其发展的特点是手术专业知识的增长和器械的改进。这种治疗的各个方面都进行了研究，增加了临床证据并持续优化。本文的目的是提供 TAVI 治疗领域的快速变化的概述，简要描述过去的主要成就，并讨论残留的挑战。
